MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
NanoXplore (TSE:GRA) reported fourth-quarter fiscal 2026 revenue of CAD 33.9 million, up 7% from a year earlier, as recovery in PACCAR and Volvo program volumes and new business offset comparisons affected by unusually high tooling revenue in the prior-year period.
Chief Financial Officer Pedro Aze
Walmart (NASDAQ:WMT) said it is maintaining a focus on price investments, faster fulfillment and expanding digital services as it seeks to build market share, while managing continued inflation and regulatory pressure in pharmacy.
During a discussion with Goldman Sachs analyst Kate McShane, a Walma
Realty Income (NYSE:O) highlighted its expanding private-capital strategy, international growth opportunities and selective investments in newer property categories during Bank of America’s 2026 Global Real Estate Conference.
Jonathan Pong, the company’s chief financial officer and treasurer, said
Doug Petno, co-president and CEO of the Commercial and Investment Bank at JPMorgan Chase & Co. (NYSE:JPM), said the bank expects broad-based strength in investment banking and markets during the third quarter, while emphasizing that the firm is maintaining underwriting and capital-allocation dis
General Motors (NYSE:GM) Chief Financial Officer Paul Jacobson said the automaker’s business is tracking consistently with its expectations for the third quarter, supported by resilient consumer demand, disciplined inventory management and production running near maximum levels across its system.
S
3M (NYSE:MMM) Chairman and CEO Bill Brown said the company is making progress on operational execution, product innovation and structural transformation as it works toward targets outlined at its 2027 investor day.
Speaking at a company news event, Brown said his approximately 2.5 years leading 3M
European gas storage sits near 67% capacity, below EU targets, as shipping constraints tighten supply. Equinor, Cheniere Energy, and Shell stand to benefit from widening transatlantic price spreads.
Healthcare stocks Eli Lilly, UnitedHealth Group, and Johnson & Johnson offer options for investors of different ages, combining growth potential, turnaround momentum, and reliable dividends.
Gilead Sciences (NASDAQ:GILD) executives outlined plans to expand the company’s HIV prevention and treatment franchises while advancing oncology and inflammation programs, with Chairman and Chief Executive Officer Dan O’Day describing the company as being at an “inflection point in value.”
Speaking
Curaleaf took a hostile, $4-per-share cash-and-stock tender offer for Aurora Cannabis directly to shareholders after private merger talks stalled, seeking global scale ahead of federal cannabis reforms.
Home Depot (NYSE:HD) executives said the retailer’s second-quarter performance exceeded its original forecast, supported by broad-based strength in core home-improvement categories, delivery investments and continued gains with professional customers despite pressure on consumer sentiment.
Richard
Forgent Power Solutions (NYSE:FPS) reported record fourth-quarter and full-year fiscal 2026 results, driven by demand across its data center, grid and industrial markets, as well as growth in its modular Powertrain Solutions business.
Fourth-quarter revenue rose 94% year over year to $462 million,
High Tide (NASDAQ:HITI) reported record third-quarter fiscal 2026 results, with management highlighting growth in both its Canadian retail cannabis business and German medical cannabis distribution operations.
For the quarter ended July 31, 2026, revenue rose 33% year over year and 11% sequentially
Netflix and Meta Platforms lead recent analyst downgrades yet retain bullish consensus ratings, while Lululemon faces a Reduce rating amid fundamental brand and growth concerns.
NVIDIA's new CUDA-Q Logical software links GPUs with quantum processors to tackle error correction, potentially benefiting IonQ, Rigetti, and D-Wave as hybrid computing advances.
AbbVie (NYSE:ABBV) executives outlined a pipeline and business-development strategy centered on immunology, neuroscience, oncology and obesity, while highlighting plans to expand beyond the company’s established SKYRIZI and RINVOQ franchises.
Speaking at a Morgan Stanley event, Chairman and Chief E
Rumble signed a six-year, $13.7 billion AI hosting deal with Anthropic, shifting its business toward compute infrastructure and shares rose 11.6% as short sellers faced a squeeze.
The Commerce Department awarded $100 million CHIPS Act grants each to D-Wave Quantum, Rigetti Computing, and Quantinuum, while IonQ was notably excluded from this funding round.
Dave & Buster's stock hit a record low after weak Q2 results, but positive free cash flow, improving comps, and analyst price targets suggest deep value and a potential bottom.
Lowe's Companies (NYSE:LOW) expects the second half of the year to resemble the first half as elevated interest rates and broader uncertainty continue to affect home-improvement spending, Chairman, President and Chief Executive Officer Marvin Ellison said at the Goldman Sachs Global Consumer and Ret
Alphabet shares rose after its P/E fell near 17.5, a discount to the S&P 500, while a 22-year nuclear power deal with Fortum and Buy-rated analyst support point to long-term strength.
Wells Fargo & Company (NYSE:WFC) Chief Financial Officer Mike Santomassimo said the bank continues to see strong consumer spending, healthy credit trends and expanding business activity as it pursues growth following the removal of its asset cap.
Speaking at a financial conference, Santomassimo sai
SEALSQ (NASDAQ:LAES) reported sharply higher revenue and gross profit for the first half of 2026, while widening operating losses as the company increased spending on post-quantum security products, certifications, acquisitions and its broader quantum technology strategy.
Revenue rose 131% to $11.2
Vera Bradley (NASDAQ:VRA) reported higher second-quarter fiscal 2027 revenue and a return to profitability from continuing operations, as growth in its direct-to-consumer business offset a planned decline in indirect-channel sales.
Consolidated revenue increased 1.1% to $71.6 million from $70.9 mil
SpaceX's Nasdaq-100 weighting will more than double at the Sept. 18 rebalance as lockup expirations expand its float, forcing index funds to buy billions in shares.
Atlassian (NASDAQ:TEAM) CFO James Chuong told investors at Citi’s TMT conference that artificial intelligence is becoming a tailwind for the company, citing increased adoption of its Rovo AI capabilities, expanding cloud usage and demand for its bundled product collections.
Chuong, who said he had
LightPath Technologies posted 73% YOY revenue growth and a swelling backlog as it pivots to defense optics, earning a Moderate Buy consensus despite wider net losses.
UBS upgraded Allegiant Travel to Buy with a $107 target after shares fell 28%, citing strong asset backing, Sun Country synergies, and contracted cargo revenue.
Fiserv (NASDAQ:FISV) CEO Takis Georgakopoulos said the company is prioritizing customer service, platform stability, product simplification and faster execution of its technology roadmap as it works to improve performance across its Financial Solutions and Merchant Solutions businesses.
Speaking al
AeroVironment won a $465 million Army laser weapon contract and posted record revenue, while Kratos and Red Cat Holdings also stand to benefit from growing military demand for high-energy laser and counter-drone technology.
Exelixis (NASDAQ:EXEL) executives outlined plans to continue expanding the CABOMETYX franchise while preparing for a potential launch of zanzalintinib, or zanza, in colorectal cancer later this year.
Speaking at a Wells biotech session, Chief Financial Officer Chris Senner said the company is worki
Kier Group (LON:KIE) reported higher revenue, profit and cash generation for fiscal 2026, while outlining a strategy centered on infrastructure and construction growth, further balance-sheet strengthening and double-digit earnings-per-share growth.
The company said revenue rose 7.5% to £4.4 billion
LSL Property Services (LON:LSL) reported higher first-half revenue, profit and margins, citing resilient activity in remortgaging, lettings and recurring revenue streams despite a modest decline in U.K. housing transactions.
Group Chief Executive Adam Castleton said the company’s markets developed
IP Group (LON:IPO) reported higher net asset value, strong cash realizations and broad portfolio activity in the first half of 2026, while management said it remains focused on converting portfolio value into shareholder returns.
Net asset value per share increased 3.2% during the half year to 114p
MJ Gleeson (LON:GLE) reported higher revenue for the year ended June 2026 as increased home completions and its first full year of partnership delivery lifted volumes, though group profit declined amid margin pressure in housebuilding and delayed land transactions.
The group said revenue rose 12.1%
Trustpilot Group (LON:TRST) reported first-half 2026 bookings growth of 18% at constant currency, supported by enterprise customer demand and a 27% increase in North American bookings, while adjusted EBITDA rose 46% to a record $26.3 million.
Chief Executive Officer Adrian Blair said the company’s
Blink Charging (NASDAQ:BLNK) outlined its progress toward profitability, an expanded build-out of DC fast-charging infrastructure and the rollout of its EnergyConnect energy-management platform during a company presentation.
The company said it has spent the past 18 months restructuring its cost ba
Pollen Street Group (LON:POLN) said its assets under management reached £8.5 billion at the end of June, split almost evenly between private equity and credit strategies, as fundraising for its fourth private credit fund supported a rise in fee-paying assets.
Lindsey McMurray said fee-paying AUM in
Wickes Group (LON:WIX) reported higher first-half revenue and adjusted profit before tax as volume growth in retail and continued momentum in its design and installation business offset a deflationary pricing environment and cost inflation.
Group revenue increased 2.1% in the first half of 2026, wh
Chewy (NYSE:CHWY) is prioritizing U.S. health services, customer spending expansion and artificial intelligence capabilities as it seeks to build on its pet retail foundation, Chief Executive Officer Sumit Singh said during a Goldman Sachs conference fireside chat.
Singh said the company’s investme
Corbus Pharmaceuticals (NASDAQ:CRBP) reported top-line results from CANYON-1, a Phase 1b trial evaluating CRB-913, an oral, peripherally restricted CB1 inverse agonist for obesity. The 12-week, placebo-controlled study enrolled 254 patients across 15 U.S. sites, with participants having an average b
Vaxart (OTCMKTS:VXRT) Chief Executive Officer Steve Lo outlined the company’s oral vaccine platform, its government-funded COVID-19 study and development opportunities in norovirus and influenza during an H.C. Wainwright conference presentation.
Lo said Vaxart’s recombinant adenovirus type 5, or Ad
Sarepta Therapeutics (NASDAQ:SRPT) outlined plans to stabilize demand for its ELEVIDYS gene therapy while advancing RNA-based programs for facioscapulohumeral muscular dystrophy, or FSHD, and myotonic dystrophy type 1, or DM1, during a Morgan Stanley Global Healthcare Conference fireside chat.
Chie
Biogen (NASDAQ:BIIB) is reshaping its business around a broader mix of neuroscience, immunology, kidney disease and ophthalmology assets, President and CEO Chris Viehbacher said during a Morgan Stanley event. The company expects a series of late-stage clinical readouts to begin as soon as next quart
Viking Therapeutics (NASDAQ:VKTX) said its obesity drug candidate VK2735 has advanced into Phase 3 development following Phase 2 results that showed approximately 15% weight loss from baseline after 13 weeks at the highest tested dose.
Speaking at the Morgan Stanley Global Healthcare Conference, Pr
Regeneron Pharmaceuticals (NASDAQ:REGN) outlined growth opportunities for Dupixent, pipeline catalysts for cemdisiran and continued commercial momentum for EYLEA HD during the Morgan Stanley Global Healthcare Conference.
Marion McCourt, Regeneron’s EVP and head of commercial, said Dupixent’s growth
Executives from Bitcoin mining and digital infrastructure companies said access to energized power, land and data-center development capabilities is creating an opportunity to serve growing artificial intelligence infrastructure demand, while also presenting significant construction, financing and r
Teva Pharmaceutical Industries (NYSE:TEVA) CEO Richard Francis said the company has progressed from the initial phase of its “Pivot to Growth” plan into its next stage, citing momentum in branded medicines, innovation, generics and biosimilars, as well as improved financial flexibility.
Speaking at
Dave & Buster's Entertainment (NASDAQ:PLAY) reported lower second-quarter revenue and earnings but said same-store sales trends improved during July and the early weeks of its third quarter as the company pursues a “back-to-basics” strategy centered on traffic, value and store execution.
Revenu
CRISPR Therapeutics (NASDAQ:CRSP) CEO Sam Kulkarni outlined the company’s commercial and clinical priorities during a Morgan Stanley discussion, highlighting continued adoption of CASGEVY and expected data updates across several pipeline programs by the end of 2026.
Kulkarni said the company’s stra
Citigroup (NYSE:C) Chief Financial Officer Gonzalo Luchetti said the bank expects full-year return on tangible common equity, or ROTCE, to finish slightly above the high end of its previously stated 10% to 11% range, citing continued momentum across its markets, banking, services and consumer busine
Kestra Medical Technologies (NASDAQ:KMTS) reported first-quarter fiscal 2027 revenue of $31 million, with President and Chief Executive Officer Brian Webster saying revenue rose 60% from a year earlier and advanced sequentially from the fourth quarter. The company raised its full-year revenue outloo
Radiant Logistics (NYSEAMERICAN:RLGT) reported higher fourth-quarter revenue, profit and adjusted EBITDA for the fiscal quarter ended June 30, 2026, as its U.S. forwarding operations, domestic services and international air freight business contributed to growth.
Net income attributable to Radiant
Evertz Technologies (TSE:ET) reported fiscal 2027 first-quarter revenue of CAD 118.3 million, up 5.5% from CAD 112.0 million a year earlier, as growth in software and services and international sales offset a slight decline in hardware revenue.
For the quarter ended July 31, 2026, the company recor
American Battery Technology (NASDAQ:ABAT) reported a more than 400% increase in fiscal 2026 revenue to $21.7 million, driven by higher throughput at its first lithium-ion battery recycling facility, expanded byproduct manufacturing and improved product pricing, Chief Executive Officer and Chief Tech
MindWalk (NASDAQ:HYFT) reported first-quarter fiscal 2027 revenue of CAD 3.8 million, up 21% from CAD 3.2 million a year earlier, as the company continued investing in commercialization of its ReefIQ biological-data platform and expanded its drug discovery partnership model.
Gross margin increased
Merck & Co., Inc. (NYSE:MRK) Chairman and CEO Rob Davis said the company’s “transformation is underway,” citing progress across product launches, clinical data readouts, business development and its Animal Health segment during a Morgan Stanley discussion.
Davis said recent pipeline readouts ha
Eli Lilly and Company (NYSE:LLY) is pursuing a broad obesity portfolio designed to address different patient needs across treatment initiation, maintenance, efficacy, tolerability and dosing convenience, according to Ilya Yuffa, the company’s executive vice president and president of Lilly USA and G
Bank of America (NYSE:BAC) Chairman and CEO Brian Moynihan said the U.S. economy remains resilient, supported by consumer spending, solid credit quality and increased borrowing activity among small and midsized businesses.
Speaking at Barclays’ Global Financial Services Conference, Moynihan said th
Adobe beat fiscal Q3 2026 estimates and raised guidance, but Semrush-driven ARR growth, weak new ARR, and deferred 2027 guidance left analysts split and shares under technical pressure.
XRP and Solana altcoin ETFs like XRPI and BSOL are drawing strong institutional inflows amid rebounding prices, though both tokens remain down significantly year to date.
Target, Hormel and Procter & Gamble, all Dividend Kings, are rebounding from depressed valuations with reliable yields, improving traffic or market share trends, and firming analyst support.
As AI spending strains free cash flow, Alphabet and Meta have halted share buybacks and share counts are rising, while Microsoft holds steady and NVIDIA posts record repurchases.
Johnson & Johnson (NYSE:JNJ) executives said the company remains on track to grow through biosimilar competition for STELARA and expects its portfolio of medicines, medical devices and pipeline programs to support accelerating growth through the end of the decade.
Speaking at a Morgan Stanley e
Despite record insider selling, Rocket Lab draws heavy institutional buying and Moderate Buy analyst ratings, backed by strong revenue growth, a $2.3 billion backlog, and the upcoming Neutron rocket launch.
Rheinmetall's Q1 miss and F126 order cancellation rattled European defense stocks, but Leonardo, Thales, and Saab show stronger order growth and cash conversion, drawing analyst upgrades.
Pfizer (NYSE:PFE) Chairman and Chief Executive Officer Albert Bourla said the drugmaker has addressed several major headwinds that weighed on investor attention, including policy uncertainty, declining COVID-19-related demand and upcoming losses of exclusivity for certain products.
Speaking at a Mo
Coda Octopus Group (NASDAQ:CODA) reported higher fiscal third-quarter revenue and pretax income, as growth in its defense engineering and acoustic businesses offset a decline in marine technology sales tied to geopolitical disruption in the Middle East and parts of Asia.
Total revenue for the quart
BATT and LIT offer diversified ETF exposure to battery and lithium stocks, with holdings in Tesla, Freeport-McMoRan, and Rio Tinto, as improving industry fundamentals support long-term growth.
After in-line August CPI data, Dell, HPE, Qualcomm, Apple and the iShares Ethereum Trust rallied Friday, with the Fed's Sept. 16 rate decision set to test whether these breakouts hold.
D-Wave Quantum shares have fallen about 40% in 2026 after weak Q2 revenue of $3.1 million, as investors seek clearer evidence of commercial and financial progress from the firm.
Regional REIT (LON:RGL) said it made progress in reducing debt, disposing of non-core properties and adding rental income during the first half of 2026, despite what Chief Executive Officer Stephen Inglis described as a subdued leasing market and continued economic uncertainty.
The company reported
Moderna (NASDAQ:MRNA) President Stephen Hoge said the company’s recently announced positive Phase III results for its investigational personalized cancer vaccine, intismeran, in adjuvant melanoma support a broader effort to use T-cell priming in multiple tumor types.
Speaking at a Morgan Stanley ev
CoinShares (NASDAQ:CSHR) reported lower revenue and profitability for the first half of 2026 as digital-asset prices fell sharply, though the company said positive client flows and a debt-free balance sheet positioned it to participate in a market recovery.
The company’s first earnings presentation
